•Inovio submitted a conditional marketing authorization application for VOCERYQ to the European Medicines Agency on November 18, 2026.
•The company expects the treatment to be available for ordering and shipment about 60 days after FDA approval, with a full launch in the first quarter of 2027.
•7 of 26 patients, or 27%, needed no surgery during the first year after treatment in the trial.
•Eli Lilly shares closed at $1,415.55 on November 17, 2026.
•The U.S. Food and Drug Administration approved Mounjaro on August 28, 2026, to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes who are at high risk.
•The SURPASS-CVOT trial included 13,299 participants at 640 sites in 30 countries.
•Trivium’s enterprise value is about $3.4 billion, or 7.1 times adjusted EBITDA for the trailing 12 months, falling to 4.8 times with expected synergies included.
•Silgan will retain a controlling 60% stake in the metal platform, compared with 40% for American Industrial Partners.
•Silgan expects $225 million in synergies by the end of the third year and adjusted earnings per share at least 15% higher.
•Net income was $39.6 million in the third quarter of 2026, compared with $31.2 million a year earlier.
•Revenue fell to $27.7 million from $50.3 million in the third quarter of 2025.
•The board approved a buyback program of up to $40.0 million, under an authorization covering 32.9 million shares, or 25% of outstanding shares, over five years.
•The investment program is worth about $7.3 billion over the life of the concession, including $1.5 billion expected from 2027 to 2031.
•Aeropuertos Argentina will provide $600 million in direct funding, while the remaining investments will be financed by funds funded through a concession fee equal to 15% of gross revenue.
•The domestic passenger usage charge rises to $9 starting December 10, 2026.
•BXDC signed an agreement to acquire a 75% stake in two joint ventures with AWS valued at about $5 billion, with an initial capitalization rate of 7.0%.
•The portfolio comprises 13 buildings across two campuses, with total IT capacity of 647 megawatts.
•AWS retains a 25% stake and leases 100% of the portfolio for an initial term of 12 years, extendable to 32 years.
•LCI shareholders will receive 1.2440 Patrick shares for each LCI share, with Patrick shareholders expected to own 52% and LCI shareholders 48% of the combined company.
•The companies received a request for additional information and documents from the U.S. Department of Justice on October 9, 2026; the waiting period runs for 30 days after substantial compliance with the request.
•LCI reported third-quarter 2026 sales of $992.5 million, compared with $1,036.5 million in the third quarter of 2025.
•The approximate value of the Cintas-UniFirst deal is $5.5 billion.
•The companies estimated operating cost savings of about $375 million over four years.
•The companies agreed with the FTC not to close the deal before December 11, 2026, unless the commission closes its investigation in writing beforehand.